Alterity Therapeutics (ATHE) Other Accumulated Expenses (2019 - 2025)

Alterity Therapeutics' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $89.29 for Q4 2025.

• On a quarterly basis, Other Accumulated Expenses fell 7.11% year-over-year to $89.29 in Q4 2025; TTM through Dec 2025 was $89.29, a 7.11% decrease from a year earlier, with the FY2025 full-year figure at $89.02, down 99.86% from the prior year.
• Other Accumulated Expenses steadied at $89.29 in Q4 2025 per ATHE's latest filing, from $89.02 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $116587.2 in Q4 2023 and bottomed at $89.02 in Q2 2025.
• The 5-year median for Other Accumulated Expenses is $16207.6 (2021), against an average of $31845.6.
• Across the five-year window, Other Accumulated Expenses jumped 259.09% in 2022 and plunged 99.92% in 2024, its largest moves.
• Year by year, Other Accumulated Expenses stood at $11049.2 in 2021, then soared by 259.09% to $39676.2 in 2022, then soared by 193.85% to $116587.2 in 2023, then plunged by 99.92% to $96.13 in 2024, then slipped by 7.11% to $89.29 in 2025.
• Per Business Quant, the three latest ATHE Other Accumulated Expenses figures stand at $89.29 (Q4 2025), $89.02 (Q2 2025), and $96.13 (Q4 2024).